Prelude Capital Management’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,529
Closed -$242K 1377
2024
Q2
$242K Sell
7,529
-4,759
-39% -$153K 0.02% 899
2024
Q1
$405K Buy
+12,288
New +$427K 0.02% 732
2023
Q3
Sell
-6,269
Closed -$236K 1214
2023
Q2
$236K Buy
+6,269
New +$252K 0.02% 770
2022
Q2
Sell
-6,621
Closed -$288K 1889
2022
Q1
$288K Buy
+6,621
New +$307K 0.01% 1088
2021
Q2
Sell
-5,911
Closed -$253K 1741
2021
Q1
$253K Sell
5,911
-99
-2% -$4.11K 0.01% 1220
2020
Q4
$249K Buy
+6,010
New +$238K 0.01% 1007
2020
Q2
Sell
-163
Closed -$5K 2055
2020
Q1
$5K Buy
+163
New +$6.38K ﹤0.01% 1224
2019
Q2
Sell
-235
Closed -$8K 1826
2019
Q1
$8K Buy
+235
New +$7.42K ﹤0.01% 1511

Other funds holding G

Prelude Capital Management's G Position: Q3 2024 in Review

Prelude Capital Management sold out of Genpact (G) in Q3 2024, closing a stake of 7,529 shares — an estimated $242K sold.

Prelude Capital Management first reported a position in G in Q1 2019 and held it in 8 quarters. The position peaked at $405K in Q1 2024. 385 funds tracked by Wall St. Rank hold G as of Q3 2024.

  • Prelude Capital Management reported no remaining Genpact position as of Q3 2024 after selling out during the quarter.
  • Prelude Capital Management sold 7,529 Genpact shares in Q3 2024, an estimated $242K.
  • Prelude Capital Management first reported a position in Genpact in Q1 2019 and held it in 8 quarters.
  • Prelude Capital Management's Genpact position peaked at $405K in Q1 2024.
  • 385 funds tracked by Wall St. Rank held Genpact as of Q3 2024.

Based on Prelude Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.